Secondary prevention in the acute and early chronic phase after ischaemic stroke and transient ischaemic attacks with antiplatelet drugs - Is antiplatelet monotherapy still reasonable?

International Journal of Clinical Practice

Volumn 65, Issue 5, 2011, Pages 531-535

  Diener, H C ^a   Weber, R ^a   Weimar, C ^a   Rother J ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b ASKLEPIOS KLINIK ALTONA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE; PLACEBO;

ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; COMBINATION CHEMOTHERAPY; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; EARLY INTERVENTION; HUMAN; LOADING DRUG DOSE; MONOTHERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT DISEASE; RISK; RISK FACTOR; SECONDARY PREVENTION; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION;

ACUTE DISEASE; ANTIBODIES, MONOCLONAL; ASPIRIN; CHRONIC DISEASE; DELAYED-ACTION PREPARATIONS; DIPYRIDAMOLE; DRUG COMBINATIONS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; ISCHEMIC ATTACK, TRANSIENT; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; SECONDARY PREVENTION; STROKE; TICLOPIDINE; TREATMENT OUTCOME;

EID: 79954471851     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2010.02621.x     Document Type: Article

References (13)

1. Giles MF, Rothwell PM,. Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2007; 6: 1063-72. (Pubitemid 350116693)
2. Chen ZM, Sandercock P, Pan HC, et al., Indications for early aspirin use in acute ischemic stroke. A combined analysis of 40 000 randomized patients from the Chinese acute stroke trial and the International stroke trial. Stroke 2000; 31: 1240-9. (Pubitemid 30351240)
3. Adams HP Jr, Effron MB, Torner J, et al., Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 2008; 39: 87-99.
4. Diener HC, Cuhna L, Forbes C, Sivenius J, Smets P, Lowenthal A,. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143: 1-13. (Pubitemid 26402780)
5. The ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial. Lancet 2006; 367: 1665-73.
6. Sacco R, Diener H, Yusuf S, et al., Randomized comparison of aspirin and extended-release dipyridamole to copidogrel for prevention of recurrent strokes. N Engl J Med 2008; 239: 1238-51.
7. Bath PM, Cotton D, Martin RH, et al., Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis. Stroke 2010; 41: 732-8.
8. Dengler R, Diener HC, Schwartz A, et al., Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial. Lancet Neurol 2010; 9: 159-66.
9. Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM,. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol 2007; 6: 961-9. (Pubitemid 47562312)
10. Diener H, Bogousslavsky J, Brass L, et al., Acetylsalicylic acid on a background of clopidogrel in high-risk patients randomised after recent ischaemic stroke or transient ischaemic attack: the MATCH trial results. Lancet 2004; 364: 331-4.
11. Geraghty OC, Kennedy J, Chandratheva A, Marquardt L, Buchan AM, Rothwell PM,. Preliminary evidence of a high risk of bleeding on aspirin plus clopidogrel in aspirin-naive patients in the acute phase after TIA or minor ischaemic stroke. Cerebrovasc Dis 2010; 29: 460-7.
12. Ho P, Peterson E, Wang L,. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA 2008; 299: 532-9. (Pubitemid 351222546)
13. Geraghty OC, Paul NL, Chandratheva A, Rothwell PM,. Low risk of rebound events after a short course of clopidogrel in acute TIA or minor stroke. Neurology 2010; 74: 1891-6.